# Acceptability and Feasibility of Extended-Release Subcutaneous Buprenorphine on a Mobile Pharmacy Clinic

> **NCT07176351** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Yale University** · enrollment: 60 (estimated)

## Conditions studied

- Opioid Use Disorder

## Interventions

- **DRUG:** Buprenorphine

## Key facts

- **NCT ID:** NCT07176351
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2027-02
- **Final completion:** 2027-02
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-04-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07176351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07176351, "Acceptability and Feasibility of Extended-Release Subcutaneous Buprenorphine on a Mobile Pharmacy Clinic". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07176351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*